https://www.selleckchem.com/products/Sunitinib-Malate-(Sutent).html Delivering ophthalmic drugs to the target tissues in eye is challenging due to transport barriers. Rapid tear clearance of the drug instilled as eye drops to treat anterior segment diseases results in a low ocular permeability of 1-5%. The blood-retina barrier and clearance mechanisms which eliminate drug from tears and ocular tissue make systemic or topical delivery techniques ineffective in delivering drugs to the back of the eye. Intravitreal injections into the eye are the only viable option even though repeated monthly injections increase risk for infections and retinal detachment. Controlled and sustained drug delivery could reduce the frequency of injections and lower the associated risk of side effects. Oleogels comprising of 10% (w/w) ethyl cellulose as the gelator in soybean oil are loaded with metformin HCl and timolol maleate above the solubility limit resulting in a dispersion of the drug particles in the gelled oil. In an alternative approach, hydrophilic drugs are dissolved in the water phaation. Binding of drugs to the gelator decreases the effective diffusivity further increasing the release duration. Chronic inflammation is known to cause alterations in vascular homeostasis that directly affects blood vessel morphogenesis, angiogenesis, and tissue permeability. These phenomena have been investigated and exploited for targeted drug delivery applications in the context of cancers and other disease processes. Vascular pathophysiology and its associated genes and signaling pathways, however, have not been systematically investigated in patients with chronic rhinosinusitis (CRS). Understanding the interplay between key vascular signaling pathways and top biomarkers associated with CRS may facilitate the development of new targeted delivery strategies and treatment paradigms. Herein, we report findings from a gene meta-analysis to identify key vascular pathways and top genes involved in